Leukaemia Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who were diagnosed with their condition at age 18 or younger
• People whose diagnosis showed a specific genetic marker called the Philadelphia chromosome, confirmed by laboratory testing of the chromosomes, along with a specific gene change called BCR::ABL1 (either e13a2 or e14a2 type)
• People whose condition was diagnosed at an early stage, known as "chronic phase," based on established European medical guidelines
• People whose first treatment was a type of drug called a tyrosine kinase inhibitor (TKI)
• People who may have received a drug called hydroxyurea before starting their main treatment
• People for whom a DNA sample taken at the time of diagnosis is available
• For a smaller group within the trial: people for whom an RNA sample (another type of genetic material) taken at diagnosis is also available (confirm with trial site)

Who may not be able to join:

• People who were older than 18 years at the time of their diagnosis
• People whose condition was diagnosed at a more advanced stage, known as "accelerated phase" or "blastic phase"
• People whose first treatment was something other than a tyrosine kinase inhibitor (TKI)

Important: Always verify eligibility with the trial site directly before applying.